FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2136738215> ?p ?o ?g. }

• W2136738215 endingPage "11599" @default.
• W2136738215 startingPage "11585" @default.
• W2136738215 abstract "// Fang Liu 1, 2, 3, * , Qing-Hua Cao 4, * , De-Jian Lu 2, * , Bin Luo 2 , Xiao-Fang Lu 4 , Rong-Cheng Luo 3 , Xiao-Guang Wang 2 1 Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China 2 Faculty of Forensic Medicine, ZhongShan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China 3 Cancer Center and Traditional Chinese Medicine-Integrated Hospital, Southern Medical University, Guangzhou 510315, China 4 Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China * These authors have contributed equally to this work Correspondence to: Xiao-Guang Wang, e-mail: wxguang@mail.sysu.edu.cn Rong-Cheng Luo, e-mail: luorc01@163.com Keywords: TMEM16A, invasion, prognosis, gastric cancer, TGF-β Received: October 02, 2014      Accepted: February 19, 2015      Published: March 23, 2015 ABSTRACT TMEM16A is a newly identified calcium activated chloride channel, and has been reported to be overexpressed by various solid malignant cancers to promote proliferation and invasion, yet little is known about its role in gastric cancer(GC). Therefore, we investigated the role of TMEM16A in GC and its clinical significance by a retrospective analysis of 367 GC patients, and in vitro study was performed for validation and underlying molecular mechanism. TMEM16A was significantly upregulated and amplified in GC tissues, and its overexpression was positively correlated with disease stage, negatively with patient survival and identified as an independent prognostic factor for patient outcome. A negative correlation between TMEM16A and E-cadherin was found in 367 GC specimens. TMEM16A silencing significantly decreased calcium activated chloride currents, impaired TGF-β secretion, reduced E-cadherin expression, and inhibited the migration and invasion without affecting proliferation of GC cells (AGS and BGC-823). Supplement of TGF-β reverted the effects of TMEM16A silencing on E-cadherin expression, cell migration and invasion. In conclusion, TMEM16A promotes invasion and metastasis in GC, and might be a novel prognostic biomarker and potential therapeutic target in the treatment of GC." @default.
• W2136738215 created "2016-06-24" @default.
• W2136738215 creator A5009378050 @default.
• W2136738215 creator A5038151589 @default.
• W2136738215 creator A5056813172 @default.
• W2136738215 creator A5061994232 @default.
• W2136738215 creator A5078739680 @default.
• W2136738215 creator A5081253774 @default.
• W2136738215 creator A5085025467 @default.
• W2136738215 date "2015-03-23" @default.
• W2136738215 modified "2023-09-28" @default.
• W2136738215 title "TMEM16A overexpression contributes to tumor invasion and poor prognosis of human gastric cancer through TGF-β signaling" @default.
• W2136738215 cites W1593424849 @default.
• W2136738215 cites W1981913135 @default.
• W2136738215 cites W1992270036 @default.
• W2136738215 cites W1995747944 @default.
• W2136738215 cites W1996708800 @default.
• W2136738215 cites W2002141156 @default.
• W2136738215 cites W2020709644 @default.
• W2136738215 cites W2027951311 @default.
• W2136738215 cites W2041069496 @default.
• W2136738215 cites W2042337677 @default.
• W2136738215 cites W2043714472 @default.
• W2136738215 cites W2046992400 @default.
• W2136738215 cites W2048015797 @default.
• W2136738215 cites W2057259759 @default.
• W2136738215 cites W2059516713 @default.
• W2136738215 cites W2068253537 @default.
• W2136738215 cites W2078571865 @default.
• W2136738215 cites W2085030832 @default.
• W2136738215 cites W2086185520 @default.
• W2136738215 cites W2086338128 @default.
• W2136738215 cites W2087810003 @default.
• W2136738215 cites W2091581429 @default.
• W2136738215 cites W2092893236 @default.
• W2136738215 cites W2095655618 @default.
• W2136738215 cites W2099916828 @default.
• W2136738215 cites W2107144403 @default.
• W2136738215 cites W2110083175 @default.
• W2136738215 cites W2111751035 @default.
• W2136738215 cites W2116945755 @default.
• W2136738215 cites W2117478547 @default.
• W2136738215 cites W2119349677 @default.
• W2136738215 cites W2129033989 @default.
• W2136738215 cites W2133766224 @default.
• W2136738215 cites W2154797313 @default.
• W2136738215 cites W2161080750 @default.
• W2136738215 cites W2163634091 @default.
• W2136738215 cites W2167657321 @default.
• W2136738215 cites W2168360292 @default.
• W2136738215 cites W2169964349 @default.
• W2136738215 cites W2279770316 @default.
• W2136738215 cites W271357513 @default.
• W2136738215 doi "https://doi.org/10.18632/oncotarget.3412" @default.
• W2136738215 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4484478" @default.
• W2136738215 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25839162" @default.
• W2136738215 hasPublicationYear "2015" @default.
• W2136738215 type Work @default.
• W2136738215 sameAs 2136738215 @default.
• W2136738215 citedByCount "70" @default.
• W2136738215 countsByYear W21367382152015 @default.
• W2136738215 countsByYear W21367382152016 @default.
• W2136738215 countsByYear W21367382152017 @default.
• W2136738215 countsByYear W21367382152018 @default.
• W2136738215 countsByYear W21367382152019 @default.
• W2136738215 countsByYear W21367382152020 @default.
• W2136738215 countsByYear W21367382152021 @default.
• W2136738215 countsByYear W21367382152022 @default.
• W2136738215 countsByYear W21367382152023 @default.
• W2136738215 crossrefType "journal-article" @default.
• W2136738215 hasAuthorship W2136738215A5009378050 @default.
• W2136738215 hasAuthorship W2136738215A5038151589 @default.
• W2136738215 hasAuthorship W2136738215A5056813172 @default.
• W2136738215 hasAuthorship W2136738215A5061994232 @default.
• W2136738215 hasAuthorship W2136738215A5078739680 @default.
• W2136738215 hasAuthorship W2136738215A5081253774 @default.
• W2136738215 hasAuthorship W2136738215A5085025467 @default.
• W2136738215 hasBestOaLocation W21367382151 @default.
• W2136738215 hasConcept C121608353 @default.
• W2136738215 hasConcept C126322002 @default.
• W2136738215 hasConcept C142724271 @default.
• W2136738215 hasConcept C143998085 @default.
• W2136738215 hasConcept C188947578 @default.
• W2136738215 hasConcept C204787440 @default.
• W2136738215 hasConcept C502942594 @default.
• W2136738215 hasConcept C71924100 @default.
• W2136738215 hasConceptScore W2136738215C121608353 @default.
• W2136738215 hasConceptScore W2136738215C126322002 @default.
• W2136738215 hasConceptScore W2136738215C142724271 @default.
• W2136738215 hasConceptScore W2136738215C143998085 @default.
• W2136738215 hasConceptScore W2136738215C188947578 @default.
• W2136738215 hasConceptScore W2136738215C204787440 @default.
• W2136738215 hasConceptScore W2136738215C502942594 @default.
• W2136738215 hasConceptScore W2136738215C71924100 @default.
• W2136738215 hasIssue "13" @default.
• W2136738215 hasLocation W21367382151 @default.
• W2136738215 hasLocation W21367382152 @default.
• W2136738215 hasLocation W21367382153 @default.

• next